Pratap C. Naha

Pratap C. Naha is a seasoned professional in the fields of gene therapy, pharmacology, toxicology, and nanotechnology, currently serving as Director at Ocugen since November 2019, overseeing pre-clinical development and leading programs related to nanobiotechnology. With a progressive career at Ocugen, prior roles included Associate Director and Principal Scientist, focusing on drug delivery and the pharmacological evaluation of gene therapies. Naha's academic background includes a PhD in Pharmacology and Toxicology from Technological University Dublin, supplemented by postdoctoral research at the University of Pennsylvania and research positions at the Dublin Institute of Technology and National Institute of Immunology.